-
Zhongguancun Life Park's six innovation service platforms completed to assist new drug development
2023/03/21
-
AliCloud, NVIDIA and Base&Byte co-hosted the "Evolution on Cloud" 2022 Global AI BioSmart Drug Competition, which concluded successfully in Shenzhen.
2023/03/14
-
Cloud Computing Accelerates the Development of Life Science Industry, Base&Byte Partners with AliCloud to Build Zhongguancun AI New Drug Development Platform
2023/02/22
-
Beijing Changping District Life Science Industry Cluster Selected for National "List" with the Help of Zhongguancun AI New Drug R&D Platform
2023/01/14
-
Base&Byte and Wuxi Biortus enter into strategic partnership
2022/10/25
-
Base&Byte Chi Ying: Gathering efforts to develop the first AI-based macromolecular drug into the clinic
2022/07/01
-
Base&Byte joins hands with Dragon Lizard Community to create a new chapter in AI pharmaceutical R&D
2022/03/01
-
The first public platform for AI new drug R&D in China has landed in Zhongguancun, and Base&Byte promotes new drug R&D into the era of intelligence.
2021/12/20
